| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 79 |
| 1 | INFLIXIMAB | 73 |
| 2 | USTEKINUMAB | 23 |
| 3 | VEDOLIZUMAB | 18 |
| 4 | AZATHIOPRINE | 17 |
| 5 | FOLIC ACID | 10 |
| 6 | METHOTREXATE SODIUM | 10 |
| 7 | PREDNISONE | 10 |
| 8 | ACETAMINOPHEN | 9 |
| 9 | METHOTREXATE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLYCERIN 20% | 2 | 0.1176 |
| 1 | NIACINAMIDE, ZINC GLYCINATE, LEVOMEFOLATE CALCIUM, CUPRIC OXIDE, SELENIUM AND CHROMIUM | 1 | 0.0278 |
| 2 | DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE | 1 | 0.0132 |
| 3 | TOLCAPONE | 1 | 0.0028 |
| 4 | IOVERSOL | 4 | 0.0010 |
| 5 | LANTHANUM CARBONATE | 4 | 0.0008 |
| 6 | FERRIC CITRATE | 1 | 0.0005 |
| 7 | HYPROMELLOSE | 1 | 0.0004 |
| 8 | REMIFENTANIL HYDROCHLORIDE | 1 | 0.0004 |
| 9 | PREDNISOLONE SODIUM PHOSPHATE | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 75 |
| 1 | Corticosteroid [EPC] | 26 |
| 2 | Interleukin-12 Antagonist [EPC] | 23 |
| 3 | Interleukin-23 Antagonist [EPC] | 23 |
| 4 | Integrin Receptor Antagonist [EPC] | 18 |
| 5 | Purine Antimetabolite [EPC] | 18 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 7 | Vitamin B12 [EPC] | 14 |
| 8 | Proton Pump Inhibitor [EPC] | 12 |
| 9 | Vitamin C [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-12 Antagonist [EPC] | 23 | 0.0002 |
| 1 | Interleukin-23 Antagonist [EPC] | 23 | 0.0002 |
| 2 | Parenteral Iron Replacement [EPC] | 3 | 0.0002 |
| 3 | Integrin Receptor Antagonist [EPC] | 18 | 0.0002 |
| 4 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 6 | Purine Antimetabolite [EPC] | 18 | 0.0002 |
| 7 | Radiographic Contrast Agent [EPC] | 4 | 0.0002 |
| 8 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 9 | Hedgehog Pathway Inhibitor [EPC] | 1 | 0.0001 |